Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Rambam Health Care Campus.
Recruitment status was:  Recruiting
Information provided by:
Rambam Health Care Campus Identifier:
First received: September 13, 2005
Last updated: April 10, 2007
Last verified: March 2007
The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Condition Intervention
Non-Small Cell Lung Carcinoma
Venous Thromboembolism
Procedure: Blood sample withdrawal

Study Type: Observational
Study Design: Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Resource links provided by NLM:

Further study details as provided by Rambam Health Care Campus:

Estimated Enrollment: 100
Study Start Date: June 2005

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Histologically or cytologically confirmed diagnosis of NSCLC.
  • normal serum bilirubin
  • informed concent to participate in the study

Exclusion Criteria:

  • anticoagulant therapy
  • infectious disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00192829

Contact: Galit Sarig, Ph.D +972-4-8543503
Contact: Nissim Haim, M.D

Hematology Laboratory Recruiting
Haifa, Israel
Contact: Galit Sarig, Ph.D    +972-4-8543523   
Principal Investigator: Galit Sarig, Ph.D         
Oncology Institution, Rambam Health Campus Recruiting
Haifa, Israel
Contact: Nissim Haim, M.D   
Principal Investigator: Nissim Haim, M.D         
Sponsors and Collaborators
Rambam Health Care Campus
Principal Investigator: Galit Sarig, Ph.D Rambam Health Care Campus
  More Information

Publications: Identifier: NCT00192829     History of Changes
Other Study ID Numbers: Thrombosis and cancer.CTIL
Study First Received: September 13, 2005
Last Updated: April 10, 2007

Keywords provided by Rambam Health Care Campus:
Lung cancer

Additional relevant MeSH terms:
Venous Thromboembolism
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Carcinoma, Bronchogenic
Bronchial Neoplasms
Hematologic Diseases processed this record on April 28, 2017